Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.
Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.
£2.5m National Lottery bid secured for the Forest of Dean https://t.co/tmjdioqnFJ
25 April 2017
© Abingdon Health 2017